A new paper just published in the Journal of Bioethical Inquiry uses extensive Freedom of Information Act findings to detail an extremely troubling off-label medical intervention employed in the U.S. on pregnant women to intentionally engineer the development of their fetuses for sex normalization purposes.
Karla Satchell, PhD, associate professor in microbiology-immunology, and her team of toxin biologists are trying to learn what makes Vibrio vulnificus, found in shellfish, so deadly.
Mark Bevan, PhD, associate professor in physiology, has been granted a Jacob Javits Neuroscience Investigator Award by the National Institute of Neurological Disorders and Stroke (NINDS).
Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that has recently completed the first human Phase 1 clinical trial for the drug.
Three scientists from Northwestern University Feinberg School of Medicine have been awarded the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the United States government to outstanding scientists and engineers who are in the early stages of their independent research careers.
With a number of recent studies showing the accuracy of magnetic resonance elastography in diagnosing and staging liver damage, Frank Miller, MD, professor in radiology, is researching its validity.
Stephan Schuele, MD, MPH, associate professor of neurology and physcial medicine and rehabilitation, is building a first-of-its-kind network to address sudden unexplained death in epilepsy (SUDEP), which accounts for an estimated 20 percent of epilepsy-related deaths, Schuele is hoping to increase the availability of data available to researchers.
Turning concussion theories into a verified model is the basis of a new Northwestern study on concussive events among grade-schoolers.
Researcher Chyung-Ru Wang, PhD, professor in microbiology-immunology, aims to test the ability of lipid vaccines to offer resistance to mycobacterium tuberculosis infection.
A weekly stress management program for patients with multiple sclerosis prevented the development of new brain lesions, a marker of the disease’s activity in the brain, according to new Northwestern Medicine research.